Science topic
Urinary Tract Infections - Science topic
Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
Questions related to Urinary Tract Infections
a. The Prevalence of Bladder Catheterization Associated with Urinary Tract Infections among Comatose Patients in Intensive Care Unit in King Fahd Military Medical Complex, Hospital.
b. The Effect of Daily Visitors on Fewer Somatic Complaints among Hospitalized patients in Medical Male Ward, King Fahd Military Medical Complex, Hospital.
What would you expect from a molecular test in cUTI in terms of antibiotic stewardship and health economics?
(My) Key consideration to tackle:
- Pathogens in cUTI (single, mulitplex panel, CFU sensitivity, "priority" pathogens vs. rare significant pathogens)
- Most interesting antibiotic resistance markes (mcr-1, oxa...)?
- Hands on time and Time to result?
- Near patient or central lab testing?
- Which patient cohort would benefit the most from a rapid molecular cUTI test (ICU, oncology ward, neonates, elderly patients...)
- Other considerations (e.g differential diagnosis, price, reimbursement, NGS/WGS, Big data, in-silico analysis, one-health, clinical trials etc...)
favorite publication/guidelines:
Wagenlehner, F.M.E., and Naber, K.G. (2006). Current challenges in the treatment of complicated urinary tract infections and prostatitis. Clin. Microbiol. Infect. 12 - PMID: 16669930
Grabe, M.B.T., Botto, H., Cek, M., Naber, K.G., Pickard, R.S., Tenke, P., Wagenlehner, F., and Wullt, B. (2015). EAU guidelines on urological infections. Uroweb 2015.
Caliendo, A.M., et al. (2013). Better tests, better care: improved diagnostics for infectious diseases. Clin. Infect. Dis. 57 - PMID: 24200831
I am trying to work on my graduate essay and need to get ideas for how to create a survey on pre and post-knowledge of UTIs and the importance of clean catch in inpatient elderly amongst nurses, as well as, their beliefs and attitudes.
I want to know all prescription drugs which are FDA approved compounds for infection like Urinary Tract Infections along with their causative agents. Can you guide me about any resource, database or any website etc.?
Urinary Tract Infection is more likely to occur in young women especially those who are sexually active or pregnant, which puts them at a higher risk for the infection. It can be a single-episode of Urinary Tract Infection or a recurrent UTI. The incidences of Enterococcus faecalis and Escherichia coli shows to be significantly higher in patients with infection than those who had single-episode urinary tract infection. E. faecalis is known to be the most common and make structural changes. Adherent E. coli is also more likely to have an important role in the etiology of young women who have recurrent UTI. Both of these bacteria are known to cause mild to serious diseases. So the question is, what clinical signs and symptoms will distinguish recurrent UTI from a single-episode UTI?
The most common bacteria that can cause Urinary Tract Infection is the Escherichia coli, but it is not the only one and the only species that can cause Urinary Tract Infection, so to I want to start a discussion about this so we can Identify and protect ourselves from this species of bacteria.
I am having problem obtaining the desired confluency. They are not growing out well even after 24-72 h incubation. Confluency remains less than 60%
Note: - Media is RMPI 1640 (As recommended by ATCC)
- Cells are new (just ordered from ATTC)
- Seeding rate is 1-2 x10^4 cells/cm^2
- Media color after incubation is orange
Looking forward towards kind replies :)
Purple urine in the bag is a known entity.
Blood and urine examinations normal
68 yr-old man
Rheumatic athritis. No renal lithiasis.
TURP in 2010 (adenoma, 55 grams)
And relapse of dysuria because of giant stone in prostatic bed...
Lithotripsy, urinalysis (once he had corynebacterium glucuronolyticum in 2013)
TURP again and again under antibiotics...
In 2016 Holep (complete), ,no bacteriuria, carboapatite and brushite stones...
Recurrence in 2017...
Any idea ?
Thank you.
I am beginning to model Urinary Tract Infection (UTI),but I have not seen any mathematical paper /model so far, That could help me to start how to model this troubling disease,I will be glad if I get some inputs on how to go about. Thanks
Dear colleagues,
Excuse me for bothering you.
I am writing you requesting your opinion and even advice.
We are investigating uropathogens and metabolomic changes in the urine of patients with urinary tract infections. Our metabolomics lab is located approximately 600 kms far from us. We intend to collect
urine samples from patients, store and send them once a week or two. I've read in the article from Siddiqui et al, (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872872/) they have stored samples up to 4-6 hours by adding boric acid and protease inhibitor.
Is described methodology also reliable for longer time? Did anyone experience similar procedures?
Are there any alternatives to keep samples intact for a longer time frame?
Thank you all in advance.
male post op bladder repair and partial cystectomy patients on tds tranexamic acid complain of pain and discomfort ( localized mostly at tip of penis) these patients are catheterized and complain of pain when clots pass through.. they also complain of a lot of pain when their bladder is irrigated via syringing to remove clots.
Different possibilities exist. Is there some struvite or high level of carbonation of apatite in the kidney stone (both through measurements by FTIR spectroscopy)? There is another solution; are there some bacterial imprints at the surface of the kidney stone (observations through SEM)? But in that case there are no bacterial imprints at the surface of struvite kidney stones. We propose an explanation related to the size of the crystals. Does anybody have another explanation?
Which drug can be used as monotherapy in BPH/LUTS . Tadalafil vs Tamsulosin.
Tadalafil was shown to be significantly effective for improving LUTS/BPH. Significant improvements in IPSS and the IIEF score were also observed in patients with comorbid BPH and ED.
I experienced several cases in which data shows liver dysfunction or cholestasis in patients with urinary traction infection without cholangitis. My impression about this phenomenon is that blood culture and/or urine culture reveal positive results. I suppose that cytokines in bloodstream produced by microbes may affect liver as well as renal function. Does anybody know this mechanism or articles discussing this point?
My question refers to interventions like catheter insertion and catheter maintenance.
I only know three indications: 1. Pregnant women, 2. patients undergoing prostate surgery or other invasive urologic surgery, and 3. kidney or kidney pancreas organ transplant patients within the first year of receiving the transplant. But I don´t have evidence in patients with single kidneyy.
January 12, 2015. doi:10.1001/jamainternmed.2014.7132
I need some audits about this topic
Would it be from a certain lab or hospital?
If so, can you include any contact information?
(Location: Cairo-Egypt)
Can we use fosfomicyn to treat the especially urinary tract infection with Pseudomonas spp?, some sources is said that there is intrinsic antibiotic resistance against fofomycin in pseudomonas spp. Besides, fosfomycin is an anbiotic class to determine pseudomonas MDRO and there is not any information about intrinsic resistance on ECDC guidelines (about MDRO 2011). So which one is right? Can we use fosfomycin to pseudomonas in urinary tract?
I am trying tio establish a number of women who are affected by UTI, but can only find vague percentage statistics. Any fair guess is welcome.
I saw a seriously recurrent UTI patient who has allergies to abx like bactrim, penicillin, cipro, rocephine and augmentin in an ICU ward recently.
He was given tramadol and citravescent for this time admission.
Unfortunately, he acquired a bad face rash and was itching badly until it swelled and scorched. A piriton was given together with a moisturiser to minimise the effect.
Upon query, he said he has no issue with tramadol for his other maladies but citravescent is the only new thing that made him itch immediately upon consumption.
When he brought up the issues to his medical-in-charge, his claim was dismissed outrightly. The next day the same thing happened, he decided to stop taking it totally and the itch, swell and scorching face returned to normal.
He is on Nitrofurontoin and has since been discharged.
Judging by his experience, while some patients or doctors found citravescent "safe", why others still feel the danger lurks everytime it is consumed?
Could it be that his immune system was very down then?
Or is it true citravescent is resistant to some patients, UTIs' especially?
Is there any evidence? Is it common to see Coagulase-negative Staphylococci urinary tract infection or bacteriuria and calcium phosphate stone (apatite) instead of triple phosphate or struvite?
Thank you!
Wisit
E.g. using phytodrugsor NSAIDs only for UTI symptoms with no antibiotics
For anti-adhesive effect of drug material against upec
It is biological plausible that antibiotic coating should reduce CAUTI but are there research papers that confirm it or otherwise?
In a study that compares rates of UTIs following placement of indwelling catheters vs intermittent straight catheters what method of statistical analysis should be used?
Application of estrogen locally per vagina in elderly females suffering of lower urinary tract symptoms showed some improvement of their symptoms with an unknown mechanism of action, and most of studies done in that subject showed only the histological evidence of improved vaginal mucosal layer, but the question is there any evidence of bladder functional and histological changes. And consequently is there any research about effects of intravesical instillation of oestrogen?
On examination, young male with normal built looking healthy.
LABS
CBC normal
UREA CREAT normal
URINE D/R norma
URINE C/S no growth
ULTRASOUND normal bladdar ok no wall thickness no postvoid residual urine.
Even Urethrogram normal.
after multiple visits i advised cystoscopy that again normal...
WHAT TO DO NEXT.
because pt still symptomatic after lot of medical prescriptions
One of the targets of the Regional Action Plan for Neglected Tropical Diseases in the the Western Pacific Region (2012-2016) is elimination of schistosomiasis in Cambodia, China and the Lao People's Democratic Republic by 2016.
I've seen several prescriptions containing combination of quinolone + 3rd generation cephalosporine in treatment of enetric infections and UTI.
The SPC/license of fosfomycin in Ireland does not recommend its use in the elderly "due to diminished urinary excretion". What is the experience of its use in other countries, have there been issues regarding poor effectiveness or resistance?
I have found a urine sample with Schistosoma mansoni ova (lateral spikes!) and wondered how comes even with the repeated sample collection and on an account that the patient has no any clinical features suggestive of ano-rectal fistula?
In the acute phase of the infection, there are several therapeutic options, even with B-lactams despite their low prostatic penetration that could be an option in countries with high resistance rates to quinolones. But once the uroculture is positive we have to choose ATB with good prostatic penetration.
Our first option would be ciprofloxacin 500 mg/12h (or 750 mg/12h, what do you think?) Or cotrimoxazole 160/800 mg/12h.
If we decide to treat with a third generation cefalospirin such as cefixim the dose would probably be 400 mg/day (or 400 mg/12h, what do you think?).
In case of an acute prostatitis due to Enterococcus: amoxicillin 500 mg/8h.
Another doubt would be regarding the duration of treatment: 2 vs 4 weeks.
What are your thoughts?
Our research project is evaluating the effects of chinese herbs on the treatment of urinary tract infections. We are now looking at specific effects of herbs on the fimbriation process.
I need to examine the urinary tract in mice for UTIs and need to extract the kidneys and bladder for histological examination. I planned to fix the tissue samples in 10% NBF for 24 hours, but I have conflicting reports on procedures for storage post-fixation. I've been told to store them in 0.1M PBS, while another colleague has said that she's stored samples in NBF up to 5 days. I've found online resources that say to store in 70% EtOH after washing the tissues well with PBS. What's the best/proper procedure?
Open stent insertion didn't work, as he is suffering from recurrent UTI and the ureter diameter in the pelvis on USS is 2.2 cm. What are the options? What can be done?